FDA clears COVID boosters for all adults

The U.S. Food and Drug Administration on Friday morning authorized the Pfizer-BioNTech and Moderna COVID-19 boosters for use in all adults, The Washington Post reports. The authorization is a "one-size-fits-all strategy" aimed at both hardening Americans' defenses against the virus" and "widening the booster campaign" to contend with a recent increase in cases, per the Post and The Wall Street Journal.
The Friday decision "essentially makes an additional dose a standard part of COVID-19 vaccinations now," writes the Journal, though some states have already expanded eligibility. Anyone 18 and older and at least six months past their second dose of the vaccine is qualified under the FDA's guidelines.
The move also reflects efforts to get ahead of waning vaccine efficacy, especially as the holidays approach, writes the Post.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The FDA will now pass the torch to the Centers for Disease Control and Prevention, which must also sign off on the authorization before its final approval. The agency is expected to make a decision in accordance with the FDA's by the end of Friday, possibly expanding booster access for millions of Americans as soon as this weekend.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
The week's best photos
In Pictures A sea of kites, a game of sand hockey, and more
By Anahi Valenzuela, The Week US
-
G20: Viola Davis stars in 'ludicrous' but fun action thriller
The Week Recommends The award-winning actress plays the 'swashbuckling American president' in this newly released Prime Video film
By The Week UK
-
The Masters: Rory McIlroy finally banishes his demons
In the Spotlight McIlroy's grand slam triumph will go down as 'one of the greatest and most courageous victories in the history of golf'
By The Week UK
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
By Peter Weber, The Week US
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
By Peter Weber, The Week US
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
By The Week US
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US